Skip to main content

HER-2 in breast cancer--methods of detection, clinical significance and future prospects for treatment

Rampaul, Raj, Pinder, S.E., Gullick, William J., Robertson, J.F., Ellis, Ian O. (2002) HER-2 in breast cancer--methods of detection, clinical significance and future prospects for treatment. Critical Reviews in Oncology Hematology, 43 (3). pp. 231-244. ISSN 1040-8428. (doi:10.1016/S1040-8428(01)00207-4) (Access to this publication is currently restricted. You may be able to access a copy if URLs are provided) (KAR id:3984)

PDF (HER-2 in Breast Cancer)
Language: English

Restricted to Repository staff only
Contact us about this Publication
[thumbnail of HER-2 in Breast Cancer]
Official URL


The Human Epidermal Growth Factor (HER-2) oncogene encodes a transmembrane tyrosine kinase receptor with extensive homology to the Epidermal Growth Factor Receptor (EGFR) which is the prototypal member of this family of receptor tyrosine kinases. HER-2 gene amplification is found in 20-30% of breast cancers. Various methods such as immunohistochemistry, southern and slot blotting, enzyme immunoassays and fluorescence in situ hybridization have all been employed to evaluate HER-2 gene and protein abnormalities. Of these immunohistochemistry is the most frequently employed but there are valid indications for the other avaliable methods. However, it is prudent that whichever methods employed are standardized, especially those that possess may have a degree of subjectivity in their assesment.

Item Type: Article
DOI/Identification number: 10.1016/S1040-8428(01)00207-4
Uncontrolled keywords: HER-2; Immunohistochemistry; FISH
Subjects: Q Science
R Medicine > RC Internal medicine > RC254 Neoplasms. Tumors. Oncology
Divisions: Divisions > Division of Natural Sciences > School of Biosciences
Depositing User: William Gullick
Date Deposited: 04 Sep 2008 14:02 UTC
Last Modified: 16 Feb 2021 12:16 UTC
Resource URI: (The current URI for this page, for reference purposes)
  • Depositors only (login required):


Downloads per month over past year